Advances in diabetes for the millennium: the heart and diabetes

David S H Bell1

  • 1University of Alabama School of Medicine, Birmingham, USA.

Insights

Diabetes significantly increases ischemic heart disease risk, especially in women. While poor glycemic control raises coronary disease risk, improving glucose management shows limited impact on cardiovascular mortality, suggesting other factors like insulin resistance are key.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetes mellitus elevates ischemic heart disease risk 2-4 times, with earlier onset and higher prevalence in women.
  • Poor glycemic control is linked to increased coronary disease risk, yet improved glucose management has not significantly reduced cardiovascular mortality.
  • Multiple factors contribute to cardiovascular damage in diabetes, including hypertension, dyslipidemia, abnormal clotting, and vascular reactivity.

Purpose of the Study:

  • To explore the complex relationship between diabetes and cardiovascular disease (CVD).
  • To investigate the potential mechanisms underlying increased CVD risk in diabetic patients.
  • To examine the relative importance of hyperglycemia versus insulin resistance in CVD development.

Main Methods:

  • Review of existing literature on diabetes, glycemic control, and cardiovascular outcomes.
  • Analysis of potential mediating factors for cardiovascular damage in diabetes.
  • Comparison of the efficacy of interventions targeting hypertension, hypercholesterolemia, and glycemic control.

Main Results:

  • Hypertension and hypercholesterolemia treatments have been more effective in reducing cardiovascular mortality than HbA1c reduction.
  • Lifestyle factors like diet, exercise, and smoking influence some diabetes-related CVD risk factors.
  • The primary driver of CVD in diabetes remains debated, with a focus on insulin resistance versus hyperglycemia.

Conclusions:

  • Cardiovascular risk in diabetes is multifactorial, involving more than just hyperglycemia.
  • Targeting insulin resistance may offer greater cardioprotection than solely focusing on insulin secretion or glycemic control.
  • Further research is needed to elucidate the role of insulin resistance in diabetes-related cardiovascular complications.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...